South Korea precision medicine market size is projected to exhibit a growth rate (CAGR) of 5.10% during 2025-2033. The rising demand for personalized healthcare solutions tailored to individual genetic profiles, rapid advancements in genomics, presence of robust healthcare infrastructure, collaborations between research institutions, expansion of pharmaceutical companies, and burgeoning healthcare expenditure are some of the factors stimulating the market growth.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Growth Rate (2025-2033) | 5.10% |
Precision medicine, also known as personalized medicine, is a cutting-edge approach to medical treatment that tailors healthcare decisions, practices, interventions, and products to individual patients. It is rooted in the recognition that each person's genetic makeup, lifestyle, and environment can significantly impact their health and response to medical treatments. One of the fundamental aspects of precision medicine is the utilization of genetic information through techniques, such as genomic sequencing. By analyzing a person's deoxyribonucleic acid (DNA), scientists and healthcare professionals can identify specific genetic variations that may contribute to diseases or affect how a patient responds to medications. This information can be used to create tailored treatment plans, and selecting the right medications and therapies that are most likely to be effective for an individual. It is particularly significant in oncology, where it has revolutionized cancer treatment. By understanding the genetic mutations driving a patient's cancer, oncologists can prescribe targeted therapies that specifically attack those mutations, leading to improved treatment outcomes and fewer side effects compared to traditional chemotherapy. Additionally, precision medicine is being used in areas like cardiovascular diseases, neurology, and rare genetic disorders.
The South Korea precision medicine market is influenced by several key drivers, such as the rising demand for personalized healthcare solutions, stemming from the increasing awareness of the benefits of tailoring medical treatments to individual genetic profiles. This is further amplified by advancements in genomic research and technology, enabling more accurate diagnoses and targeted therapies. Moreover, South Korea's robust healthcare infrastructure plays a pivotal role in fostering the precision medicine market. The country boasts a well-developed healthcare system and a high level of healthcare access, which facilitates the integration of precision medicine into clinical practice. In line with this, government initiatives supporting precision medicine have also been instrumental in propelling the market growth. Furthermore, collaborations and partnerships between research institutions, pharmaceutical companies, and healthcare providers are accelerating the market growth. These collaborations accelerate research and development (R&D) efforts, promote knowledge sharing, and facilitate the translation of research findings into clinical applications. Moreover, substantial investments in the South Korean precision medicine sector and rapid infrastructure development are positioning South Korea as a competitive player in the global precision medicine landscape.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2025-2033. Our report has categorized the market based on product, technology, application, and end user.
Product Insights:
The report has provided a detailed breakup and analysis of the market based on the product. This includes consumables, instruments, and services.
Technology Insights:
A detailed breakup and analysis of the market based on the technology have also been provided in the report. This includes big data analytics, bioinformatics, gene sequencing, drug discovery, companion diagnostics, and others.
Application Insights:
The report has provided a detailed breakup and analysis of the market based on the application. This includes oncology, central nervous system (CNS), immunology, respiratory medicine, infections, and others.
End User Insights:
A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals and clinics, diagnostic centers, pharma and biotech companies, healthcare IT firms, and others.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include Seoul Capital Area, Yeongnam (Southeastern Region), Honam (Southwestern Region), Hoseo (Central Region) and Others.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | US$ Million |
Scope of the Report | Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
|
Products Covered | Consumables, Instruments, Services |
Technologies Covered | Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Others |
Applications Covered | Oncology, Central Nervous System (CNS), Immunology, Respiratory Medicine, Infections, Others |
End Users Covered | Hospitals and Clinics, Diagnostic Centers, Pharma and Biotech Companies, Healthcare IT Firms, Others |
Regions Covered | Seoul Capital Area, Yeongnam (Southeastern Region), Honam (Southwestern Region), Hoseo (Central Region), Others |
Customization Scope | 10% Free Customization |
Report Price and Purchase Option | Single User License: US$ 3699 Five User License: US$ 4699 Corporate License: US$ 5699 |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |